| Literature DB >> 25320964 |
Jonas Kosten1, Andres Binolfi, Marchel Stuiver, Silvia Verzini, Francois-Xavier Theillet, Beata Bekei, Marleen van Rossum, Philipp Selenko.
Abstract
S129-phosphorylated alpha-synuclein (α-syn) is abundantly found in Lewy-body inclusions of Parkinson's disease patients. Residues neighboring S129 include the α-syn tyrosine phosphorylation sites Y125, Y133, and Y136. Here, we use time-resolved NMR spectroscopy to delineate atomic resolution insights into the modification behaviors of different serine and tyrosine kinases targeting these sites and show that Y125 phosphorylation constitutes a necessary priming event for the efficient modification of S129 by CK1, both in reconstituted kinase reactions and mammalian cell lysates. These results suggest that α-syn Y125 phosphorylation augments S129 modification under physiological in vivo conditions.Entities:
Keywords: Alpha-synuclein; NMR; Parkinson’s disease; casein kinase 1; kinetics; phosphorylation
Mesh:
Substances:
Year: 2014 PMID: 25320964 DOI: 10.1021/cn5002254
Source DB: PubMed Journal: ACS Chem Neurosci ISSN: 1948-7193 Impact factor: 4.418